Clinical trial
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
NCT03065192 is registered in ClinicalTrials.gov with Neurocrine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
- Lead sponsor
- Neurocrine Biosciences
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 11, 2017
- Completion date
- August 10, 2021
- Enrollment
- 16 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
basal ganglia disease, brain diseases, central nervous system diseases, idiopathic parkinson's disease, movement disorders, nervous system diseases, neurodegenerative diseases, parkinson's disease, parkinsonian disorders